MABS1253MI

MilliporeSigma™ O-GlcNAc, Mouse, Unlabeled, Clone: RL1,

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 MABS1253MI-Each-of-1 In Stock ₹ 42,968.31

MABS1253MI - Each of 1

₹ 42,968.31

In Stock

Quantity

1

Base Price: ₹ 42,968.31

GST (18%): ₹ 7,734.296

Total Price: ₹ 50,702.606

Antigen

O-GlcNAc

Classification

Monoclonal

Concentration

Please refer to lot specific datasheet.

Formulation

Purified mouse IgM in buffer containing PBS without preservatives.

Immunogen

Nuclear pore complex-lamina fraction isolated from rat liver nuclear envelopes.

Quantity

100 μL

Research Discipline

Signaling

Test Specificity

Both clone RL1 & clone RL2 (Mfr. No. MABS157) target O-linked N-acetylglucosamine (GlcNAc) modified (GlcNAcylated) proteins. GlcNAc removal by beta-N-acetylglucosaminidase treatment or galactosylation of GlcNAc on target proteins by galactosyltransferase treatment greatly reduced the immunoreactivity of clone RL1 & RL2 toward their target proteins. The binding affinity of RL1 and RL2 toward a given GlcNAcylated protein is dependent on both O-GlcNAc and the adjacent core protein structure (Snow, C.M., et al. (1987). J. Cell Biol. 104(5):1143-11560; Holt, G.D., et al. (1987). J. Cell Biol. 104(5):1157-1164).

Content And Storage

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze

Isotype

IgM κ

Applications

Immunoassay, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, Inhibition Assays

Clone

RL1

Conjugate

Unconjugated

Host Species

Mouse

Purification Method

Purified by Ion-Exchange Chromatography

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Drosophila

Form

Purified

Related Products

Img

MilliporeSigma™

MABC949

--

Img

MilliporeSigma™

MAB427CMI

--

Img

MilliporeSigma™

MABD402MI

--

Img

MilliporeSigma™

MABF919MI

--

Img

MilliporeSigma™

MABS1916MI

--

Img

MilliporeSigma™

MABF245

--

Img

MilliporeSigma™

MABF917MI

--

Img

MilliporeSigma™

MABN1783MI

--

Description

  • Posttranslational modification of proteins by -linked N-acetylglucosamine ( -GlcNAc) via the hydroxyl moieties on serine or threonine residues is termed O-linked -GlcNAc or simply O-GlcNAc
  • O-GlcNAc is one of the most abundant posttranslational modifications within the nucleocytoplasmic compartments of all animals and plants
  • Unlike other types of protein glycosylations, O-GlcNAc occurs exclusively within the nuclear and cytoplasmic compartments and is generally not further modified to form more elongated structures
  • In addition, O-GlcNAcylation is a highly dynamic and reversible process
  • The O-GlcNAc transferase (OGT) attaches O-GlcNAc to proteins at specific serine or threonine residues, while O-GlcNAcase catalyzes the removal/hydrolysis of O-GlcNAc from proteins
  • In fact, a dynamic interplay between O-GlcNAcylation and serine/threonine phosphorylation plays an important role in regulating cellular signaling
  • Tau and RNA polymerase II (Pol II) are two well known proteins that undergo modification by O-GlcNAcylation
  • In Alzheimer's diseased human brains, tau becomes extensively phosphorylated and less O-GlcNAcylated
  • Similarly, O-GlcNAc is removed and replaced with O-phosphate on the Poly II CTD when the elongation phase of transcription is initiated.